Sponsor:
Natalie Denburg
Code:
NCT03954899
Conditions
Mild Cognitive Impairment
Cognitive Decline
Healthy Aging
Eligibility Criteria
Sex: All
Age: 56 - 70+
Healthy Volunteers: Accepted
Interventions
melatonin
placebo
Brief summary:
Conditions
Mild Cognitive Impairment
Cognitive Decline
Healthy Aging
Study ID
NCT03954899
Start date
Nov 12, 2019
Status verified date
Feb, 2025
Completion date
Nov, 2025
Anticipated
Primary completion date
Nov, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 56 - 70+
Healthy Volunteers: Accepted
Enrollment
230 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: MCI+ Melatonin 5mg
placebo comparator: MCI+ placebo
experimental: MCI- Melatonin 5mg
placebo comparator: MCI- placebo
Interventions
melatonin
placebo
Primary outcome measure
Central contacts
Locations
University of Iowa Hospitals & Clinics
Recruiting
Iowa City, Iowa, United States, 52242
Contacts
Principal Investigator:
Natalie Denburg, Ph.D.
Sponsor
Natalie Denburg
Last update posted
Mar 4, 2025
Last verified
Feb, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Natalie Denburg on 2025-03-04.